Back
EyePoint Pharmaceuticals Vs. Direxion Daily S&P Biotech Bull 3X Shares Industry Stock Comparison
Sell
35
EYPT
EyePoint Pharmaceuticals
Last Price:
$5.39
Seasonality Move:
9.92%
Sell
22
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Last Price:
$44.19
Seasonality Move:
24.76%
Sell
35
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $5.38. The Score for EYPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
is a Sell
Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $44.14. The Score for LABU is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
LABU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $5.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X Shares share price today is $44.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABU is experiencing buying pressure, which is a positive indicator for future bullish movement.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 46.75 | Sell |
Chaikin Money Flow: | 796700 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.94 - 6.72) | Sell |
Bollinger Bands (100): | (5.93 - 8.41) | Sell |
LABU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.44 | Sell |
Relative Strength Index (14 RSI): | 34.94 | Sell |
Chaikin Money Flow: | 2288232 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.25 - 79.03) | Sell |
Bollinger Bands (100): | (69.52 - 109.38) | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.81 | Buy |
20-day SMA: | 5.53 | Sell |
50-day SMA: | 6.18 | Sell |
200-day SMA: | 8.23 | Sell |
8-day EMA: | 4.96 | Buy |
20-day EMA: | 5.41 | Sell |
50-day EMA: | 6.17 | Sell |
200-day EMA: | 8.61 | Sell |
LABU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46 | Sell |
20-day SMA: | 61.78 | Sell |
50-day SMA: | 76.25 | Sell |
200-day SMA: | 109.08 | Sell |
8-day EMA: | 47 | Sell |
20-day EMA: | 57.74 | Sell |
50-day EMA: | 72.23 | Sell |
200-day EMA: | 98.73 | Sell |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
EyePoint Pharmaceuticals Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |